Ethical Considerations Related to the Use of Mechanical Support in Congenital Heart Disease

World Journal for Pediatric and Congenital Heart Surgery

Volumn 4, Issue 1, 2013, Pages 70-74

  Rossano, Joseph W ^a   Kaufman, Beth D ^a   Rame, J Eduardo ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BVAD; circulatory assist devices (LVAD; congenital heart disease; ethics; heart failure; RVAD; TAH)

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CONGENITAL HEART DISEASE; DECISION MAKING; ECONOMIC ASPECT; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL DISCHARGE; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL ETHICS; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE;

BVAD; CIRCULATORY ASSIST DEVICES (LVAD; CONGENITAL HEART DISEASE; ETHICS; HEART FAILURE; RVAD; TAH);

ADULT; CHILD; ETHICS, MEDICAL; HEART DEFECTS, CONGENITAL; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS;

EID: 84888067881     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135112469040     Document Type: Article

References (30)

1. Hoffman JI Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002; 39(12):1890–1900.
2. Williams RG Pearson GD Barst RJ, et al, Report of the national heart, lung, and blood institute working group on research in adult congenital heart disease. J Am Coll Cardiol. 2006; 47(4):701–707.
3. Rossano JW Kim JJ Decker JA,, et al Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012; 18(6):459–470.
4. Rodriguez FH Moodie DS Parekh DR, et al, Outcomes of heart failure related admissions in adults with congenital heart disease in the United States: a population based study (abstract). J Am Coll Cardiol. 2011; 57: E460.
5. Shaddy RE Boucek MM Hsu DT,, et al Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007; 298(10):1171–1179.
6. Kirk R Edwards LB Kucheryavaya AY,, et al The Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Heart Transplantation Report—2011. J Heart Lung Transplant. 2011; 30(10):1095–1103.
7. Stehlik J Edwards LB Kucheryavaya AY, et al, The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report—2011. J Heart Lung Transplant. 2011; 30(10):1078–1094.
8. Almond CS Thiagarajan RR Piercey GE, et al, Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009; 119(5):717–727.
9. United Network of Organ Sharing Website. http://optn.transplant.hrsa.gov/latestData. Accessed May 27, 2012.
10. Hunt SA Abraham WT Chin MH, et al, ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005; 112(12):e154–e235.
11. Morales DL Almond CS Jaquiss RD, et al, Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant. 2011; 30(1):1–8.
12. Mackling T Shah T Dimas V, et al, Management of Single-Ventricle Patients With Berlin Heart EXCOR Ventricular Assist Device: Single-Center Experience. Artif Organs. 2012; 36(6):555–559.
13. Blume ED Naftel DC Bastardi HJ Duncan BW Kirklin JK Webber SA. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006; 113(19):2313–2319.
14. Simpson KE Cibulka N Lee CK Huddleston CH Canter CE. Failed Fontan heart transplant candidates with preserved vs impaired ventricular ejection: 2 distinct patient populations. J Heart Lung Transplant. 2012; 31(5):545–547.
15. Copeland JG Copeland H Gustafson M, et al, Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg. 2012; 143(3):727–734.
16. Slaughter MS Rogers JG Milano CA, et al, Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361(23):2241–2251.
17. Seyfarth M Sibbing D Bauer I, et al, A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52(19):1584–1588.
18. Rose EA Gelijns AC Moskowitz AJ, et al, Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med. 2001; 345(20):1435–1443.
19. Hetzer R Alexi-Meskishvili V Weng Y, et al, Mechanical cardiac support in the young with the Berlin Heart EXCOR pulsatile ventricular assist device: 15 years’ experience. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006: 99–108.
20. Reinhartz O Stiller B Eilers R Farrar DJ. Current clinical status of pulsatile pediatric circulatory support ASAIO J. 2002; 48(5):455–459.
21. Stiller B Hetzer R Weng Y, et al, Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transplant. 2003; 22(11):1201–1208.
22. Arabia FA Tsau PH Smith RG, et al, Pediatric bridge to heart transplantation: application of the Berlin Heart, Medos and Thoratec ventricular assist devices. J Heart Lung Transplant. 2006; 25(1):16–21.
23. Imamura M Dossey AM Prodhan P, et al, Bridge to cardiac transplant in children: Berlin Heart versus extracorporeal membrane oxygenation. Ann Thorac Surg. 2009; 87(6):1894–1901.
24. Almond CS Buchholz H Massicotte P, et al, Berlin heart EXCOR pediatric ventricular assist device investigational device exemption study: study design and rationale. Am Heart J. 2011; 162(3):425–435.
25. United States Food and Drug Administration. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm302715.htm. Accessed May 27, 2012.
26. Law SP Kim JJ Decker JA,, et al Hospital charges for pediatric heart transplant hospitalizations in the United States from 1997 to 2006. J Heart Lung Transplant. 2012; 31(5):485–491.
27. Slaughter MS Bostic R Tong K Russo M, Rogers JG Temporal changes in hospital costs for left ventricular assist device implantation. J Card Surg. 2011; 26(5):535–541.
28. Rogers JG Bostic RR Tong KB Adamson R Russo M Slaughter MS. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail. 2012; 5(1):10–16.
29. Moreno SG Novielli N Cooper NJ. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transplant. 2012; 31(5):450–458.
30. Stein ML Robbins R Sabati AA, et al, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)-defined morbidity and mortality associated with pediatric ventricular assist device support at a single US center: the Stanford experience. Circ Heart Fail. 2010; 3(6):682–688.